AAC
ABBV icon

Asset Advisors Corp’s AbbVie ABBV Stock Holding History

Asset Advisors Corp’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$9.88M Sell
106,665
-1,730
-2% -$169K 1.72% 19
2018
Q1 		$10.3M Buy
108,395
+980
+0.9% +$108K 1.73% 18
2017
Q4 		$10.4M Buy
107,415
+100
+0.1% +$9.43K 1.7% 20
2017
Q3 		$9.54M Sell
107,315
-100
-0.1% -$7.61K 1.7% 20
2017
Q2 		$7.79M Sell
107,415
-100
-0.1% -$6.72K 1.4% 25
2017
Q1 		$7.01M Sell
107,515
-2,130
-2% -$134K 1.28% 27
2016
Q4 		$6.87M Sell
109,645
-1,524
-1% -$93K 1.37% 26
2016
Q3 		$7.01M Buy
111,169
+8,364
+8% +$541K 1.46% 22
2016
Q2 		$6.37M Buy
102,805
+7,000
+7% +$427K 1.32% 25
2016
Q1 		$5.47M Buy
95,805
+10,850
+13% +$605K 1.18% 29
2015
Q4 		$5.03M Buy
84,955
+1,475
+2% +$85K 1.13% 31
2015
Q3 		$4.54M Buy
83,480
+1,480
+2% +$96.3K 1.11% 31
2015
Q2 		$5.51M Buy
82,000
+5,400
+7% +$353K 1.23% 28
2015
Q1 		$4.48M Sell
76,600
-4,525
-6% -$273K 1.01% 37
2014
Q4 		$5.31M Buy
81,125
+1,150
+1% +$72.5K 1.17% 31
2014
Q3 		$4.62M Buy
79,975
+2,450
+3% +$136K 1.06% 34
2014
Q2 		$4.38M Buy
77,525
+19,650
+34% +$1.03M 0.99% 37
2014
Q1 		$2.98M Buy
57,875
+3,100
+6% +$157K 0.7% 46
2013
Q4 		$2.89M Buy
54,775
+18,940
+53% +$931K 0.69% 47
2013
Q3 		$1.6M Buy
35,835
+11,285
+46% +$500K 0.46% 49
2013
Q2 		$1.01M Buy
+24,550
New +$1.07M 0.3% 63

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Asset Advisors Corp's ABBV Position: Q2 2018 in Review

Asset Advisors Corp reduced its AbbVie (ABBV) stake by 1.6% in Q2 2018, selling an estimated $169K and leaving 106,665 shares worth $9.88M. The position accounts for 1.72% of the portfolio, ranked #19.

Asset Advisors Corp first reported a position in ABBV in Q2 2013 and has held it in 21 quarters since. The position peaked at $10.4M in Q4 2017. 1,996 funds tracked by Wall St. Rank hold ABBV as of Q2 2018.

  • Asset Advisors Corp held 106,665 shares of AbbVie worth $9.88M as of Q2 2018.
  • Asset Advisors Corp sold 1,730 AbbVie shares in Q2 2018, an estimated $169K.
  • AbbVie made up 1.72% of Asset Advisors Corp's portfolio in Q2 2018, its #19 holding.
  • Asset Advisors Corp first reported a position in AbbVie in Q2 2013 and has held it in 21 quarters since.
  • Asset Advisors Corp's AbbVie position peaked at $10.4M in Q4 2017.
  • 1,996 funds tracked by Wall St. Rank held AbbVie as of Q2 2018.

Based on Asset Advisors Corp's 13F filing for Q2 2018, filed 20 Jul 2018.